Faculty profile

Antonio Giulivi

Back to faculty

Associate ProfessorPathology and Laboratory MedicineUniversity of Ottawa

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial
The Journal of Heart and Lung Transplantation · 2025
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation.
Cytotherapy · 2022
A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.
International journal of chronic obstructive pulmonary disease · 2021

All 33 publications

Latest funding

Safety and Efficacy of a Therapeutic Platelet Transfusion Strategy in Outpatients
CIHR · 2011 · Co-investigator
$150,031

All 1 grants and awards

33 publications.

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial

Stewart DJ, Mehta S, Chandy G, Hirani N, Granton J, Hambly N, Swiston J, Danovitch K, Sabri E, Giulivi A

The Journal of Heart and Lung Transplantation20256 citations

DOI: 10.1016/j.healun.2025.05.012

The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation.

Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP

Cytotherapy2022

DOI: 10.1016/j.jcyt.2021.09.006 PMID: 34688545

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.

Cowan J, Mulpuru S, Abdallah SJ, Chopra A, Purssell A, McGuinty M, Alvarez GG, Giulivi A, Corrales-Medina V, MacFadden D, Boyle L, Hasimja D, Thavorn K, Mallick R, Aaron SD, Cameron DW

International journal of chronic obstructive pulmonary disease2021

DOI: 10.2147/copd.s338849 PMID: 34887657

Exploring Peaks in Hospital Blood Component Utilization: A 10-Year Retrospective Study at a Large Multisite Academic Centre.

Perelman I, Fergusson D, Lampron J, Mack J, Rubens F, Giulivi A, Tokessy M, Shorr R, Tinmouth A

Transfusion medicine reviews2021

DOI: 10.1016/j.tmrv.2020.10.002 PMID: 33341326

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding

Xu Y, Schulman S, Dowlatshahi D, Holbrook AM, Simpson CS, Shepherd LE, Wells PS, Giulivi A, Gomes T, Mamdani M

Thrombosis Research201916 citations

DOI: 10.1016/j.thromres.2019.07.026

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?

Rodger MA, Le Gal G, Langlois NJ, Gin B, Mallick R, Giulivi A, Freedman M, Kovacs MJ, REVERSE II investigators

Thrombosis research2018

DOI: 10.1016/j.thromres.2018.07.020 PMID: 30031290

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.

Cowan J, Mulpuru S, Aaron S, Alvarez G, Giulivi A, Corrales-Medina V, Thiruganasambandamoorthy V, Thavorn K, Mallick R, Cameron DW

Pilot and feasibility studies2018

DOI: 10.1186/s40814-018-0327-z PMID: 30116551

Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study

Xu Y, Schulman S, Dowlatshahi D, Holbrook AM, Simpson CS, Shepherd LE, Wells PS, Giulivi A, Gomes T, Mamdani M

Chest201784 citations

DOI: 10.1016/j.chest.2017.02.009

Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study.

Castellucci LA, Shaw J, Giulivi A, Edwards C, Carrier M, Patel R

Thrombosis research2016

DOI: 10.1016/j.thromres.2016.05.026 PMID: 27294776

Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication.

Laderoute MP, Larocque LJ, Giulivi A, Diaz-Mitoma F

The open AIDS journal2015

DOI: 10.2174/1874613601509010112 PMID: 26793281

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Antonio Giulivi

Research

Latest papers

Latest funding

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial

The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation.

A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD.

Exploring Peaks in Hospital Blood Component Utilization: A 10-Year Retrospective Study at a Large Multisite Academic Centre.

Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?

Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbations.

Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study

Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - The PACER pilot study.

Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication.

Safety and Efficacy of a Therapeutic Platelet Transfusion Strategy in Outpatients

Frequent collaborators

Dar Dowlatshahi

Lothar Huebsch

Alan Tinmouth

Juthaporn Cowan

Sam Schulman

Anne Marie Holbrook

Jason Tay

Kednapa Thavorn

Tara Gomes

Kednapa Thavorn

Sunita Mulpuru

Muhammad Mamdani

Kednapa Thavorn

Christopher Bredeson

Vicente Corrales-Medina

May Griffith

David Allan

George Chandy

Jacob Karsh

Fraser Rubens

Mitchell Sabloff

Keith Fowke

Maura Ricketts

Natasha Kekre

Andrew Purssell

Harold Atkins